19 annual accounts with figures on one time axis, 20 filings since 2005
peak of €426,235 in 2010
€1,909▼ 99.0%
lowest -€485,905 in 2017
-€87,062▼ €26,382
peak of €1.1m in 2020
€820,788▼ 9.6%
€1.8m▲ 31.0%
peak of 7 FTE in 2010
-not published
Board6 names since 2013
1 directorName after signing inVisible after signing in
Documentsfilings and deeds
14-12-2025136 days late
2024micro format
Gross margin from €199,504 to €1,909Loss of €87,062Transfer of 400 shares from Name after signing inVisible after signing in to Name after signing inVisible after signing in22-07Debts from €1.3m to €1.8mCash from €4,276 to €9,922
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
XXVisible after signing in
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Score breakdown
Visible after signing inVisible after signing in
Comparable companies, two years later
In July 2024, 8,616 companies had the same profile as BIOSENSYS has now. Each dot stands for 22 companies, two years later.
94.2%
were still trading
5.2%
stopped another way
0.4%
went bankrupt
Small
20 years or older
solvency 30% or more
a small loss
Another 0.2% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
The companies in ten equal groups, from the lowest to the highest expected share
Group
Expected
Actual
1
0.2%
0.2%
2
0.3%
0.5%
3
0.5%
0.6%
4
0.7%
0.8%
5
0.9%
0.9%
6
1.3%
1.5%
7
1.6%
1.8%
8
1.8%
1.8%
9
2.9%
3.1%
10
5.6%
6.1%
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 8,616 companies, not a prediction for BIOSENSYS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit verdict
The credit verdict says how much credit you can give the company on open account. “Acceptable” means normal terms, “With conditions” means limiting the amount or the term. “Not advised” means asking for payment up front.
Visible after signing inVisible after signing in
Credit check for an amount and term of your choice
Transfer of 400 shares from Name hiddenVisible after signing in to Hidden nameVisible after signing inName after signing inVisible after signing in holds 1,600 shares · Name hiddenVisible after signing in holds 400 shares · General meeting of 01-07-2024 · Gazette deed
Hidden nameVisible after signing in appointed as managing directorName after signing inVisible after signing in holds 200 shares · General meeting of 26-09-2023 · Gazette deed
Sector peers are the companies with the same activity (NACE code) and, where stated, the same size, that the company is compared with. A percentile says how many of them do worse.
These companies have the same main activity as BIOSENSYS: renting and operating of own or leased residential real estate, excluding social housing (NACE 68201). They are comparable in size and age: total assets between €1.7m and €2.8m, founded between 1996 and 2008.
The company number of BIOSENSYS is 0871.249.941. The VAT number is the same number with BE in front: BE 0871.249.941.
Where is BIOSENSYS based?
The registered office is at Avenue des Etats-Unis 7, 6041 Charleroi.Company details
What does BIOSENSYS do?
According to the KBO register, the main activity is renting and operating of own or leased residential real estate, excluding social housing (NACE 68201).
What is the legal form of BIOSENSYS?
BIOSENSYS is a public limited company (NV).
When was BIOSENSYS founded?
BIOSENSYS was founded on 17-01-2005.
Is BIOSENSYS still active?
Yes, BIOSENSYS is an active enterprise in the KBO register.
What is the turnover of BIOSENSYS?
The turnover in financial year 2024 is ≈ €5,100. This figure is estimated from the gross margin of €1,909 and 36 comparable companies (NACE 68201). It probably lies between €3,300 and €8,500. It is a rough estimate.Financials
Is BIOSENSYS profitable?
In financial year 2024, BIOSENSYS made a loss of €87,062.
Where can I find the annual accounts of BIOSENSYS?
BIOSENSYS filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2024.